Skip to main content
logo
Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
42.00
-0.53 (-1.25%)
At close: Mar 5, 2026, 4:00 PM EST
41.28
-0.72 (-1.71%)
After-hours: Mar 5, 2026, 6:46 PM EST

Terns Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Cap
4,568483419547179-
Market Cap Growth
1202.24%15.17%-23.37%206.12%--
Enterprise Value
4,278125.86156.27264.9912.830
Last Close Price
42.005.546.4910.187.07-
PE Ratio
--4.95-5.11-6.10-3.20-
PS Ratio
----178.65-
PB Ratio
13.101.401.641.971.11-
P/TBV Ratio
13.531.271.811.331.00-
P/FCF Ratio
--6.89-6.21-11.07-4.24-
P/OCF Ratio
--6.89-6.22-11.14-4.27-
EV/Sales Ratio
----12.83-
EV/EBITDA Ratio
--1.25-1.54-4.34-0.26-
EV/EBIT Ratio
--1.24-1.52-4.27-0.26-
EV/FCF Ratio
--1.80-2.32-5.37-0.30-
Debt / Equity Ratio
0.000.000.000.000.000.19
Debt / EBITDA Ratio
-0.01-0.01-0.01-0.020.00-0.36
Debt / FCF Ratio
-0.01-0.02-0.01-0.020.00-0.43
Net Debt / Equity Ratio
-1.04-1.03-1.03-1.02-1.03-0.90
Net Debt / EBITDA Ratio
2.733.532.594.623.361.69
Net Debt / FCF Ratio
3.795.093.905.713.932.03
Asset Turnover
-0000.010
Quick Ratio
19.2122.8922.0633.4324.343.84
Current Ratio
19.5223.1422.3933.6824.483.98
Return on Equity (ROE)
-29.98%-29.56%-33.89%-27.60%-43.83%-93.36%
Return on Assets (ROA)
-32.68%-32.31%-37.02%-27.42%-38.69%-65.03%
Return on Invested Capital (ROIC)
1184.05%1299.79%2024.42%1446.60%-3646.05%-1111.40%
Return on Capital Employed (ROCE)
-34.19%-33.68%-38.33%-28.21%-43.22%-83.75%
Earnings Yield
-2.07%-20.22%-19.57%-16.40%-31.26%-
FCF Yield
-1.70%-14.51%-16.09%-9.03%-23.60%-
Buyback Yield / Dilution
-0.15%-34.06%-10.09%-30.63%-76.84%-
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q